Summary & Overview

HCPCS Q4348: Sentry SL Matrix, Per Square Centimeter (Add-On)

HCPCS Level II code Q4348 designates the Sentry SL matrix billed per square centimeter as an add-on supply to a primary surgical procedure. This code captures area-based billing for a biologic or synthetic matrix used in wound management or reconstruction and is relevant where products are charged by surface area rather than per unit. Nationally, accurate use of this add-on code affects facility and professional line-item reporting and can influence product cost accounting and episode-level spending.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of clinical context and typical sites of service, common modifiers and billing considerations, and how Q4348 functions as an add-on supply code in claims. The publication summarizes coding implications, common billing modifiers for procedure supplements, and payer alignment on add-on supply reimbursement practices where available.

This summary is intended to orient coding and revenue-cycle stakeholders to the code’s purpose, typical clinical settings, and the aspects of payer coverage and claim submission they should evaluate.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareQ4348HCPCS Level IIsurgical matrixadd-on supplywound managementprocedure billingfacility billingper square centimeterbiologic dressing

Billing Code Overview

HCPCS Level II code Q4348 represents Sentry SL matrix billed per square centimeter as an add-on item; it is reported separately in addition to a primary procedure. This code denotes a product-based supply used in surgical or wound-management procedures where the matrix is measured and billed by surface area.

Service type: Surgical product / biologic dressing

Typical site of service: Operating room, procedure suite, or outpatient surgical center

Clinical & Coding Specifications

Clinical Context

A middle-aged patient with a chronic, non-healing surgical wound on the lower leg following debridement presents to an outpatient wound care clinic. The clinician determines that advanced biologic matrix therapy is indicated to augment wound closure after inadequate progress with standard dressings and negative-pressure therapy. The clinic orders and applies a synthetic/biologic matrix product billed as Q4348 measured and documented in square centimeters. The clinical workflow includes wound assessment, measurement and debridement as needed, selection and preparation of the wound bed, application of the Sentry sl matrix per square centimeter as an add-on product to the primary procedural service (for example, wound debridement or grafting), documentation of product lot and area treated, and post-application dressing and follow-up care. Typical sites of service include hospital outpatient departments, ambulatory surgical centers, and office-based wound care clinics with appropriate sterile technique and product storage capabilities.

Coding Specifications

Modifier	Description	When to Use
`00`	Unspecified modifier (provider/system use)	Rarely used; only if payer requires an unspecified placeholder per local rules.
`22`	Increased procedural services	When work required is substantially greater than typical (more extensive debridement or complex application).
`23`	Unusual anesthesia	When general anesthesia is used for circumstances that would normally not require it for the associated primary procedure.
`52`	Reduced services	When a service described by the primary procedure was partially reduced or not completed but product application billed as add-on still occurred for a reduced area.
`53`	Discontinued procedure	When the primary procedure was started but discontinued and the matrix was applied prior to discontinuation or billed per local policy.
`54`	Surgical care only	When the surgeon bills only the operative portion and another provider bills pre/postoperative care; matrix still billed as add-on to the surgical procedure.
`55`	Postoperative management only	When only postoperative care is provided by the billing provider and the matrix application was part of postoperative wound management.
`56`	Preoperative management only	When only preoperative management is billed by one provider and another performed the procedure that included the matrix application.
`62`	Two surgeons	When two surgeons work together as primary surgeons and the matrix application is part of the shared operative service.
`78`	Return to OR for related procedure by same physician	When the patient returns to the operating room related to the original procedure and additional matrix application is performed.
`AS`	Ambulatory surgical center (ASC) facility service	When the application occurs in an ASC and billing requires ASC-specific modifier reporting.
`QX`	Modifier indicating assistance by a Certified Registered Nurse Anesthetist (CRNA)	Use when CRNA assistance is billed in conjunction with the primary procedure requiring anesthesia during matrix application.
`QY`	Medical direction of two, three, or four CRNAs	When the physician medically directs multiple CRNAs during the related service.
`SH`	Diagnostic/therapeutic services ordered by a physician, non-physician practitioner (specific to some payers)	When a non-physician practitioner orders and the payer requires `SH` for reporting ancillary services.

Taxonomy Code	Specialty	Notes
`208D00000X`	General Surgery	Common operator for surgical wound debridement and matrix placement.
`207Q00000X`	Plastic Surgery	Frequently performs wound reconstruction and biologic matrix application.
`207L00000X`	Vascular Surgery	Manages lower-extremity ischemic wounds and may use matrix adjuncts.
`364A00000X`	Wound Care Specialist	Dedicated wound care clinicians who apply advanced wound therapies in outpatient settings.
`207K00000X`	Orthopedic Surgery	May apply matrix products for traumatic or surgical wounds adjacent to musculoskeletal procedures.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.421`	Non-pressure chronic ulcer of right lower leg with fat layer exposed	Chronic lower-extremity ulcers commonly receive advanced matrix therapy to promote granulation and closure.
`L97.422`	Non-pressure chronic ulcer of left lower leg with fat layer exposed	Applicable for left-sided chronic wounds requiring biologic scaffold augmentation.
`L98.4`	Chronic ulcer of skin, not elsewhere classified	General category for chronic ulcers treated with matrix products.
`I83.019`	Varicose veins of lower extremities with ulcer, unspecified lower leg	Venous ulcers often require debridement and adjunctive matrix application for healing.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are a frequent indication for advanced wound matrices to support healing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, skin, subcutaneous tissue, first 20 sq cm or less; simple (includes only epidermis and dermis)	Often performed immediately before matrix placement to prepare the wound bed and is the primary procedure to which `Q4348` is billed as an add-on.
`11043`	Debridement, includes muscle and/or fascia, first 20 sq cm or less	Used when deeper debridement is necessary prior to application of the matrix product.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less, or for smaller contiguous areas	Used when matrix products are applied as part of skin substitute grafting; `Q4348` may be billed per square centimeter as an add-on for product units.
`97605`	Negative pressure wound therapy (NPWT) limited	NPWT may be used before or after matrix application; these services are commonly performed in the wound-care workflow.
`11045`	Debridement, includes bone, first 20 sq cm or less	When bone is involved and debridement precedes matrix application for complex wounds.